An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...

Pfizer Inc.’s maternal vaccine to protect newborns against the sometimes fatal RSV virus can be administered across the US ...

U.S. regulators have approved the first RSV vaccine for pregnant women to protect their newborns WASHINGTON -- U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their ...

The FDA approved the first vaccine for pregnant women to prevent RSV in infants. The vaccine would allow babies to be born ...

RSV is the leading cause of hospitalization for U.S. infants. The new vaccine, Pfizer's bivalent RSVpreF vaccine (trade name Abrysvo), has been shown to reduce the risk of RSV hospitalization for ...

The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...

The federal Food and Drug Administration approved the Pfizer Covid-19 vaccine for emergency use in children ages 5 to 11 this morning, opening the door for vaccinations to begin. Before that can ...

The Food and Drug Administration authorized the emergency use of its Pfizer-BioNTech vaccine for adolescents age 12 to 15 today, according to the New York Times. Authorization is given for the ...

The latest COVID-19 boosters could be approved and on their way to health systems this week. The question: Will people go and ...

A panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Friday will vote on the use of Pfizer's ...